Prognosis for marginal zone lymphoma
[PDF File]UNDERSTANDING Splenic Marginal Zone Lymphoma (SMZL)
https://info.5y1.org/prognosis-for-marginal-zone-lymphoma_1_862b57.html
Prognosis Splenic marginal zone lymphoma is a very indolent disease with an average survival of 8-10 years. Patients who fail to achieve a complete response to first-line therapy, or have a poor performance status have an inferior prognosis [10, 11]. Arcani et al. recently derived a prognostic model using three variables; Hb < 120 g/L, albumin < 35 g/L and elevated LDH based on a multivariate ...
Stage IV marginal zone B-cell lymphoma – prognostic ...
The types of cells that become cancerous in splenic marginal zone lymphoma (SMZL) are B lymphocytes (B cells). B lymphocytes make antibodies to fight infections. They are called B cells because they mature in the bone marrow. There are over 80 different subtypes of lymphoma. They fall into two main categories: • Hodgkin lymphoma (HL) • Non-Hodgkin lymphoma (NHL) SMZL is a type of NHL. …
What is Marginal Zone Lymphoma?
The prognosis of patients with MALT lymphoma varies according to the an-atomical site of origin. Cancer 2013;119:629-38. ... Marginal zone lymphoma (MZL) is an indolent, mature B-cell neoplasm recognized by the World Health Organization (WHO)classificationas3entities:nodal(NMZL),splenic(SMZL),andextranodalMZLofmucosa …
Survival of Patients With Marginal Zone Lymphoma
Marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) type has been shown to be responsible for approximately 7–8% of all NHL. In Korea, MZL accounts for 17% of all B-cell lymphomas, and is the second most frequent histological subtype, after diffuse large B-cell lymphoma. (4) The cancer staging system is used to decide the treatment modality, and also used for ...
Nearby & related entries:
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.